Oxford BioMedica is a biopharmaceutical company focused on the development of innovative treatments to improve the lives of patients with high unmet medical needs. The company’s vast pipeline of gene-based product candidates addresses the treatment of age-related or inherited neurodegenerative and ocular diseases. Oxford BioMedica and its collaborators are additionally engaged in developing novel targeted therapies and therapeutic vaccines for treating multiple types of cancer. For more information, visit the company’s Web site at www.oxfordbiomedica.co.uk.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: